608
Participants
Start Date
June 27, 2018
Primary Completion Date
July 15, 2020
Study Completion Date
November 30, 2025
Enfortumab Vedotin
Intravenous infusion
Docetaxel
Intravenous infusion
Vinflunine
Intravenous infusion
Paclitaxel
Intravenous infusion
Sidney Kimmel Center for Prostate and Urologic Cancers, New York
Montefiore Medical Center, The Bronx
White Plains Hospital Center for Cancer Care - Oncology Site, White Plains
Long Island Jewish Medical Center, Lake Success
Roswell Park Cancer Institute, Buffalo
University of Pennsylvania, Philadelphia
Fox Chase Cancer Center, Philadelphia
Saint Francis Hospital, Greenville
Florida Hospital, Orlando
Sylvester Comprehensive Cancer Center, Miami
Norton Cancer Institute, Louisville
Toledo Clinic Cancer Center, Toledo
Medical College of Wisconsin, Milwaukee
Rush University Medical Center, Chicago
Nebraska Cancer Specialists, Omaha
HOPE Cancer Center of East Texas, Tyler
University of Colorado, Denver
Innovative Clinical Research, Whittier
UCI Chao Family Comprehensive Cancer Center, Orange
University of California, Sacramento
Providence Portland Med Center, Portland
Benaroya Research Institute at Virginia Mason, Seattle
Smilow Cancer Hospital at Yale-New Haven, New Haven
Dana-Farber Cancer Institute, Boston
Lifespan Rhode Island Hospital, Providence
Site AR54001, Buenos Aires
Site AU61006, Adelaide
Site AU61001, Miranda
Site AU61004, St Leonards
Site AU61002, Sydney
Site AT43005, Linz
Site AT43001, Salzburg
Site AT43004, Vienna
Site BE32011, Aalst
Site BE32007, Brussels
Site BE32013, Brussels
Site BE32010, Charleroi
Site BE32001, Ghent
Site BE32008, Ghent
Site BE32005, Hasselt
Site BE32003, Leuven
Site BE32009, Liège
Site CA15015, Calgary
Site CA15012, Edmonton
Site CA15014, London
Site CA15002, Montreal
Site CA15007, Montreal
Site CA15011, Oshawa
Site CA15004, Québec
Site CA15008, Saskatoon
Site CA15001, Sherbrooke
Site CA15005, Toronto
Site CA15013, Vancouver
Site DK45003, Aalborg
Site DK45004, Copenhagen
Site DK45001, Herlev
Site FR33021, Besançon
Site FR33009, Bordeaux
Site FR33018, Bordeaux
Site FR33001, Brest
Site FR33016, Caen
Site FR33015, Lyon
Site FR33014, Marseille
Site FR33003, Nice
Site FR33022, Paris
Site FR33005, Pierre-Bénite
Site FR33004, Saint-Mandé
Site FR33002, Strasbourg
Site FR33019, Toulouse
Site FR33006, Villejuif
Site DE49011, Essen
Site DE49008, Heidelberg
Site DE49010, Münster
Site DE49003, Tübingen
Site DE49009, Würzburg
Site IT39008, Arezzo
Site IT39019, Cremona
Site IT39010, Milan
Site IT39025, Modena
Site IT39013, Pisa
Site IT39014, Reggio Emilia
Site IT39004, Terni
Site JP81010, Hirosaki
Site JP81014, Kashiwa
Site JP81007, Sapporo
Site JP81026, Sapporo
Site JP81020, Tsukuba
Site JP81018, Morioka
Site JP81009, Kita-gun
Site JP81002, Yokohama
Site JP81005, Sendai
Site JP81016, Sayama
Site JP81024, Takatsuki
Site JP81008, Bunkyo-ku
Site JP81012, Koto-ku
Site JP81013, Shinjuku-ku
Site JP81011, Ube
Site JP81015, Chiba
Site JP81019, Fukuoka
Site JP81023, Fukuoka
Site JP81004, Hiroshima
Site JP81001, Kyoto
Site JP81017, Niigata
Site JP81003, Okayama
Site JP81022, Osaka
Site JP81021, Tokushima
Site JP81006, Toyama
Site NL31002, Amsterdam
Site NL31003, Amsterdam
Site NL31009, Nijmegen
Site NL31001, Tilburg
Site PT35102, Lisbon
Site PT35105, Lisbon
Site PT35106, Porto
Site RU70002, Ivanovo
Site RU70009, Obninsk
Site RU70005, Omsk
Site RU70015, Vologda
Site KR82006, Daejeon
Site KR82007, Goyang-si
Site KR82012, Hwasun-gun
Site KR82002, Incheon
Site KR82001, Seongnam-si
Site KR82003, Seoul
Site KR82004, Seoul
Site KR82008, Seoul
Site KR82009, Seoul
Site KR82010, Seoul
Site KR82005, Shin
Site ES34010, Badajoz
Site ES34002, Badalona
Site ES34001, Barcelona
Site ES34012, Barcelona
Site ES34023, Barcelona
Site ES34014, Córdoba
Site ES34003, Madrid
Site ES34013, Madrid
Site ES34015, Madrid
Site ES34017, Madrid
Site ES34011, Manresa
Site ES34019, Pamplona
Site ES34005, Seville
Site ES34007, Valencia
Site ES34008, Valencia
Site CH41002, Bern
Site CH41001, Chur
Site TW88602, Kaohsiung City
Site TW88605, Kaohsiung City
Site TW88606, Taichung
Site TW88601, Tainan City
Site TW88604, Taipei
Site TW88607, Taoyuan District
Site GB44005, London
Site GB44006, London
Site GB44004, Metropolitan Borough of Wirral
Site GB44002, Sheffield
Site GB44011, Southampton
Site GB44013, Sutton
Seagen Inc.
INDUSTRY
Astellas Pharma Global Development, Inc.
INDUSTRY